Wockhardt, Cadila, Hospira Recall Drugs In The U.S.
Facebook Twitter google+ RSS Feed

Wockhardt, Cadila, Hospira Recall Drugs In The U.S.

Wednesday, 31 December 2014, 11:52 Hrs
37
cmt right
31
Comment Right
54
cmt right
16
cmt right
Printer Print Email Email


NEW DELHI: Drug firms Wockhardt, Cadila Healthcare and Hospira are voluntarily recalling certain lots of drugs in the U.S., according to the U.S. Food and Drug Administration (USFDA).



As per the information available on the USFDA website, Wockhardt USA Inc, the U.S.-based arm of the company, is recalling 11,18,400 Metoprolol Succinate extended-release tablets, a hypertension drug, for 'failed dissolution specifications'.



The tablets have been manufactured by Mumbai-based Wockhardt Ltd and distributed by Wockhardt USA LLC.



The nationwide recall has been initiated by the company on April 17 this year and initiated under Class-III which FDA defined as "a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences".



Zydus Pharmaceuticals USA Inc, the U.S.-based arm of Ahmedabad-based Cadila Healthcare is recalling 58,920 bottles of Benzonatate Capsules, used to treat coughs, due to "wet and/or leaking capsules".



The recall has been initiated by the company on November 26 and has been initiated under Class-II, which FDA states as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences.



The capsules have been manufactured by Ahmedabad-based Cadila Healthcare and distributed by Zydus Pharmaceuticals USA.



Further, Hospira is recalling 2,61,706 vials of Meropenem, an antibiotic, in the U.S., Puerto Rico, Italy, Netherlands and Spain for having "defective container".



"Glass vials may crack due to low (thin) out of specification vial wall thickness which may lead to contamination and lack of assurance of sterility," USFDA said.



The vials were manufactured by Hospira Healthcare India for Hospira, Inc. The recall has been initiated by the company on October 24 and has been initiated under Class-II. Comments from the companies could not be obtained immediately.



READ MORE: 2014 Changed The Way Indians Did Their Shopping



Seven Companies That Will Gain From RBI Rate Cut


Source: PTI
Experts on SiliconIndia
Santhosh  K
Sr. Soft. Engg.
Oracle India
Nehal Vyas
Sr. Team Lead
Cyberoam Tech.
Rani Malli
Sr. Director
Philips
Sr. Executive
ISB
Vijay Balkrishna Konduskar
Business Consultant
Imans Web Tech
Dr L P  Sharma
Technical Director
NIC
Reena Khanna
Founder
Solitaireworld
Dellas  Asse
sys-network admin
Computer Station
Write your comment now
Submit Reset
SPOTLIGHT